thymine has been researched along with Vomiting in 4 studies
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
Excerpt | Relevance | Reference |
---|---|---|
"A novel oral agent that consists of trifluridine and tipiracil hydrochloride (TFTD) has been established as salvage-line treatment for metastatic colorectal cancer (mCRC)." | 7.83 | Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study. ( Aoyama, T; Hama, T; Inoue, A; Kawakami, K; Machida, Y; Suenaga, M; Sugisaki, T; Sugita, K; Suzuki, K; Takiguchi, T; Yamaguchi, K; Yamaguchi, T; Yokokawa, T, 2016) |
"Evaluation demonstrated a trend toward thymidine protection of carboplatin-induced treatment-limiting thrombocytopenia." | 5.09 | Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer. ( Alberti, D; Arzoomanian, RZ; Cohen, JD; Feierabend, C; Jacobson, E; Katschinski, DM; Mehta, M; Olsen, M; Robins, HI; Tiggelaar, CL; Tutsch, K; Wilding, G, 1999) |
"A novel oral agent that consists of trifluridine and tipiracil hydrochloride (TFTD) has been established as salvage-line treatment for metastatic colorectal cancer (mCRC)." | 3.83 | Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study. ( Aoyama, T; Hama, T; Inoue, A; Kawakami, K; Machida, Y; Suenaga, M; Sugisaki, T; Sugita, K; Suzuki, K; Takiguchi, T; Yamaguchi, K; Yamaguchi, T; Yokokawa, T, 2016) |
" Adverse events to TAS-102 monotherapy were observed in 22 out of 23 cases (95." | 1.43 | Safety of an oral anticancer agent (trifluridine/tipiracil combination tablet) in patients with advanced and recurrent colorectal cancer. ( Asano, H; Go, M; Ito, D; Iwai, M; Kimura, M; Teramachi, H; Usami, E; Yoshimura, T, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kimura, M | 1 |
Go, M | 1 |
Iwai, M | 1 |
Ito, D | 1 |
Asano, H | 1 |
Usami, E | 1 |
Teramachi, H | 1 |
Yoshimura, T | 1 |
Sugita, K | 1 |
Kawakami, K | 1 |
Yokokawa, T | 1 |
Sugisaki, T | 1 |
Takiguchi, T | 1 |
Aoyama, T | 1 |
Suzuki, K | 1 |
Suenaga, M | 1 |
Yamaguchi, K | 1 |
Inoue, A | 1 |
Machida, Y | 1 |
Yamaguchi, T | 1 |
Hama, T | 1 |
Brussel, W | 1 |
van Kuilenburg, AB | 1 |
Janssens, PM | 1 |
Robins, HI | 1 |
Tutsch, K | 1 |
Katschinski, DM | 1 |
Jacobson, E | 1 |
Mehta, M | 1 |
Olsen, M | 1 |
Cohen, JD | 1 |
Tiggelaar, CL | 1 |
Arzoomanian, RZ | 1 |
Alberti, D | 1 |
Feierabend, C | 1 |
Wilding, G | 1 |
1 trial available for thymine and Vomiting
Article | Year |
---|---|
Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cohort Studies; Drug Administration Schedule; Drug | 1999 |
3 other studies available for thymine and Vomiting
Article | Year |
---|---|
Safety of an oral anticancer agent (trifluridine/tipiracil combination tablet) in patients with advanced and recurrent colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Combinations; Female; | 2016 |
Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study.
Topics: Abdominal Pain; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot | 2016 |
A neonate with recurrent vomiting and generalized hypotonia diagnosed with a deficiency of dihydropyrimidine dehydrogenase.
Topics: Developmental Disabilities; Dihydrouracil Dehydrogenase (NADP); Female; Homozygote; Humans; Infant; | 2006 |